
PaMeLa Co., Ltd. is a Japanese medical technology company specializing in the development of systems that objectively measure pain using brain wave data and artificial intelligence. Originating from Osaka University, the company develops compact, patient-friendly EEG-based hardware and software to visualize pain without requiring patient self-reporting. Their technology aims to standardize pain measurement globally, improving medical care quality and addressing challenges such as subjective pain reporting and opioid misuse. PaMeLa provides services to medical institutions and is advancing clinical trials to validate their pain measurement system, positioning itself as a pioneer in AI-driven pain assessment with a vision to enhance patient quality of life worldwide.

PaMeLa Co., Ltd. is a Japanese medical technology company specializing in the development of systems that objectively measure pain using brain wave data and artificial intelligence. Originating from Osaka University, the company develops compact, patient-friendly EEG-based hardware and software to visualize pain without requiring patient self-reporting. Their technology aims to standardize pain measurement globally, improving medical care quality and addressing challenges such as subjective pain reporting and opioid misuse. PaMeLa provides services to medical institutions and is advancing clinical trials to validate their pain measurement system, positioning itself as a pioneer in AI-driven pain assessment with a vision to enhance patient quality of life worldwide.